行情

ALEC

ALEC

ALECTOR, INC.
NASDAQ

实时行情|Nasdaq Last Sale

19.68
+0.09
+0.46%
交易中 14:15 09/18 EDT
开盘
19.55
昨收
19.59
最高
19.89
最低
19.39
成交量
45.44万
成交额
--
52周最高
27.00
52周最低
13.64
市值
13.45亿
市盈率(TTM)
-15.6302
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ALEC 新闻

  • Buy Bellus Health Before It Hits The Nasdaq
  • Seeking Alpha - Article.2天前
  • 美股石油股小幅上扬,埃克森美孚石油涨近1%,英国石油涨1.35%,康菲石油...
  • 新浪财经.09/11 14:37
  • 今天 茅台和中石油的“拐点”都出现了
  • 新浪财经-自媒体综合.09/11 12:57
  • Alector Initiates Phase 2 Trial of AL001 in Patients with Frontotemporal Dementia
  • GlobeNewswire.09/09 13:00

更多

所属板块

生物技术和医学研究
-1.44%
制药与医学研究
-0.46%

热门股票

名称
价格
涨跌幅

ALEC 简况

Alector, Inc. is a clinical-stage biopharmaceutical company focused on immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Immuno-neurology targets immune dysfunction as a cause of multiple pathologies that are drivers of degenerative brain disorders. The Company is developing therapies designed to simultaneously counteract these pathologies by restoring healthy immune function to the brain. The Company's platform leverages large scale human genetic datasets, advanced tools in bioinformatics and imaging, and insights into neurodegeneration and immunology to identify immune system. Its platform focuses on target selection, biomarker selection and patient selection. Its product portfolio includes AL001, AL101, Al002 and AL003. Its AL001 targets frontotemporal dementia carrying a progranulin (FTD-GRN).
展开

Webull提供Alector Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。